To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 7 January to Question 203875, when NHS England plans to make a decision on which tumour profiling tests will be available to guide adjuvant chemotherapy decisions in early breast cancer.
This answer is the replacement for a previous holding answer.
12 February 2019
The tumour profiling tests that are available to guide adjuvant chemotherapy decisions in early breast cancer will be included in the forthcoming updated National Genomic Test Directory for cancer. The forthcoming test directory will include the updated National Institute for Health and Care Excellence recommendations.